NCT05909046View on ClinicalTrials.gov

A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP)

NAActive, not recruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

July 24, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Pre-Gestational DiabetesType2diabetesPregnancy in DiabeticPregnancy, High RiskGestational DiabetesGestational Diabetes Mellitus in the Puerperium
Interventions
DIAGNOSTIC_TEST

Immediate inpatient postpartum OGTT

The intervention includes immediate inpatient postpartum 2-hour oral glucose tolerance test (OGTT) prior to delivery discharge

DIAGNOSTIC_TEST

Standard of care 4-12 week postpartum OGTT

Standard of care is 4-12 week outpatient postpartum OGTT

Trial Locations (1)

43210

The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus

All Listed Sponsors
lead

Ohio State University

OTHER